The protease-sensitive loop of the vesicular stomatitis virus matrix protein is involved in virus assembly and protein translation

Virology

Volumn 416, Issue 1-2, 2011, Pages 16-25

  Mire, Chad E ^a,b   Whitt, Michael A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Matrix protein; Vesicular stomatitis virus; Virus assembly; Virus protein translation

Indexed keywords

M PROTEIN; MATRIX PROTEIN; NUCLEOCAPSID PROTEIN; PROTEINASE; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REPORTER GENE; TRANSLATION INITIATION; VESICULAR STOMATITIS VIRUS; VIRION; VIRUS ASSEMBLY; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TRANSCRIPTION; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CRICETINAE; GENE EXPRESSION REGULATION, VIRAL; MODELS, MOLECULAR; MUTATION; PEPTIDE HYDROLASES; PROTEIN BIOSYNTHESIS; PROTEIN CONFORMATION; VESICULOVIRUS; VIRAL MATRIX PROTEINS; VIRUS ASSEMBLY;

ENCEPHALOMYOCARDITIS VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 79958067502     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.04.013     Document Type: Article

References (42)

1. Ahmed M., Lyles D.S. Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III. J. Virol. 1998, 72(10):8413-8419.
2. Ahmed M., McKenzie M.O., Puckett S., Hojnacki M., Poliquin L., Lyles D.S. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J. Virol. 2003, 77(8):4646-4657.
3. Barge A., Gagnon J., Chaffotte A., Timmins P., Langowski J., Ruigrok R.W., Gaudin Y. Rod-like shape of vesicular stomatitis virus matrix protein. Virology 1996, 219(2):465-470.
4. Black B.L., Brewer G., Lyles D.S. Effect of vesicular stomatitis virus matrix protein on host-directed translation in vivo. J. Virol. 1994, 68:555-560.
5. Brown E.L., Lyles D.S. A novel method for analysis of membrane microdomains: vesicular stomatitis virus glycoprotein microdomains change in size during infection, and those outside of budding sites resemble sites of virus budding. Virology 2003, 310(2):343-358.
6. Brown E.L., Lyles D.S. Organization of the vesicular stomatitis virus glycoprotein into membrane microdomains occurs independently of intracellular viral components. J. Virol. 2003, 77(7):3985-3992.
7. Brown C.J., McNae I., Fischer P.M., Walkinshaw M.D. Crystallographic and mass spectrometric characterisation of eIF4E with N7-alkylated cap derivatives. J. Mol. Biol. 2007, 372(1):7-15.
8. Buchholz U.J., Finke S., Conzelmann K.K. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 1999, 73(1):251-259.
9. Carroll A.R., Wagner R.R. Role of the membrane (M) protein in endogenous inhibition of in vitro transcription of vesicular stomatitis virus. J. Virol. 1979, 29:134-142.
10. Chong L.D., Rose J.K. Interactions of normal and mutant vesicular stomatitis virus matrix proteins with the plasma membrane and nucleocapsids. J. Virol. 1994, 68:441-447.
11. Connor J.H., Lyles D.S. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1. J. Virol. 2002, 76(20):10177-10187.
12. Connor J.H., Lyles D.S. Inhibition of host and viral translation during vesicular stomatitis virus infection. eIF2 is responsible for the inhibition of viral but not host translation. J. Biol. Chem. 2005, 280(14):13512-13519.
13. Connor J.H., McKenzie M.O., Lyles D.S. Role of residues 121 to 124 of vesicular stomatitis virus matrix protein in virus assembly and virus-host interaction. J. Virol. 2006, 80(8):3701-3711.
14. Faria P.A., Chakraborty P., Levay A., Barber G.N., Ezelle H.J., Enninga J., Arana C., van Deursen J., Fontoura B.M. VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol. Cell 2005, 17(1):93-102.
15. Flood E.A., Lyles D.S. Assembly of nucleocapsids with cytosolic and membrane-derived matrix proteins of vesicular stomatitis virus. Virology 1999, 261(2):295-308.
16. Fuerst T.R., Earl P.L., Moss B. Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol. Cell. Biol. 1987, 7:2538-2544.
17. Gaudier M., Gaudin Y., Knossow M. Cleavage of vesicular stomatitis virus matrix protein prevents self-association and leads to crystallization. Virology 2001, 288(2):308-314.
18. Gaudier M., Gaudin Y., Knossow M. Crystal structure of vesicular stomatitis virus matrix protein. EMBO J. 2002, 21(12):2886-2892.
19. Gaudin Y., Barge A., Ebel C., Ruigrok R.W.H. Aggregation of VSV M protein is reversible and mediated by nucleation sites: implication for viral assembly. Virology 1995, 206:28-37.
20. Gaudin Y., Sturgis J., Doumith M., Barge A., Robert B., Ruigrok R.W. Conformational flexibility and polymerization of vesicular stomatitis virus matrix protein. J. Mol. Biol. 1997, 274(5):816-825.
21. Ge P., Tsao J., Schein S., Green T.J., Luo M., Zhou Z.H. Cryo-EM model of the bullet-shaped vesicular stomatitis virus. Science 2010, 327(5966):689-693.
22. Graham S.C., Assenberg R., Delmas O., Verma A., Gholami A., Talbi C., Owens R.J., Stuart D.I., Grimes J.M., Bourhy H. Rhabdovirus matrix protein structures reveal a novel mode of self-association. PLoS Pathog. 2008, 4(12):e1000251.
23. Harty R.N., Brown M.E., McGettigan J.P., Wang G., Jayakar H.R., Huibregtse J.M., Whitt M.A., Schnell M.J. Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. J. Virol. 2001, 75(22):10623-10629.
24. Hellen C.U., Wimmer E. Translation of encephalomyocarditis virus RNA by internal ribosomal entry. Curr. Top. Microbiol. Immunol. 1995, 203:31-63.
25. Jang S.K., Pestova T.V., Hellen C.U., Witherell G.W., Wimmer E. Cap-independent translation of picornavirus RNAs: structure and function of the internal ribosomal entry site. Enzyme 1990, 44(1-4):292-309.
26. Jayakar H.R., Murti K.G., Whitt M.A. Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J. Virol. 2000, 74(21):9818-9827.
27. Lawson N.D., Stillman E.A., Whitt M.A., Rose J.K. Recombinant vesicular stomatitis viruses from DNA. Proc. Natl. Acad. Sci. U. S. A. 1995, 92(10):4477-4481.
28. Lyles D.S., McKenzie M.O., Daptur P.E., Grant K.W., Jerome W.G. Complementation of M gene mutants of vesicular stomatitis virus by plasmid-derived M protein converts spherical extracellular particles into native bullet shapes. Virology 1996, 217:76-87.
29. Mebatsion T., Weiland F., Conzelmann K.K. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J. Virol. 1999, 73(1):242-250.
30. Mire C.E., Dube D., Delos S.E., White J.M., Whitt M.A. Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix protein. J. Virol. 2009, 83(23):12139-12150.
31. Mire C.E., White J.M., Whitt M.A. A spatio-temporal analysis of matrix protein and nucleocapsid trafficking during vesicular stomatitis virus uncoating. PLoS Pathog. 2010, 6(7):e1000994.
32. Newcomb W.W., Brown J.C. Role of the vesicular stomatitis virus matrix protein in maintaining the viral nucleocapsid in the condensed form found in native virions. J. Virol. 1981, 39:295-299.
33. Newcomb W.W., Tobin G.J., McGowan J.J., Brown J.C. In vitro reassembly of vesicular stomatitis virus skeletons. J. Virol. 1982, 41(3):1055-1062.
34. Pal R., Grinnell B.W., Snyder R.M., Wagner R.R. Regulation of viral transcription by the matrix protein of vesicular stomatitis virus probed by monoclonal antibodies and temperature-sensitive mutants. J. Virol. 1985, 56(2):386-394.
35. Pestova T.V., Kolupaeva V.G., Lomakin I.B., Pilipenko E.V., Shatsky I.N., Agol V.I., Hellen C.U. Molecular mechanisms of translation initiation in eukaryotes. Proc. Natl. Acad. Sci. 2001, 98(13):7029-7036.
36. Petersen J.M., Her L.S., Varvel V., Lund E., Dahlberg J.E. The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol. Cell. Biol. 2000, 20(22):8590-8601.
37. Rigaut K.D., Birk D.E., Lenard J. Intracellular distribution of input vesicular stomatitis virus proteins after uncoating. J. Virol. 1991, 65:2622-2628.
38. Rose J.K., Buonocore L., Whitt M.A. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechniques 1991, 10:520-525.
39. Stillman E.A., Rose J.K., Whitt M.A. Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins. J. Virol. 1995, 69:2946-2953.
40. Swinteck B.D., Lyles D.S. Plasma membrane microdomains containing vesicular stomatitis virus M protein are separate from microdomains containing G protein and nucleocapsids. J. Virol. 2008, 82(11):5536-5547.
41. Whitlow Z.W., Connor J.H., Lyles D.S. Preferential translation of vesicular stomatitis virus mRNAs is conferred by transcription from the viral genome. J. Virol. 2006, 80(23):11733-11742.
42. Whitlow Z.W., Connor J.H., Lyles D.S. New mRNAs are preferentially translated during vesicular stomatitis virus infection. J. Virol. 2008, 82(5):2286-2294.